You have 9 free searches left this month | for more free features.

C1 INH

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

End Stage Renal Disease, Chronic Kidney Diseases Trial in Los Angeles (Berinert, Placebo)

Active, not recruiting
  • End Stage Renal Disease
  • Chronic Kidney Diseases
  • Los Angeles, California
    Cedars Sinai Medical Center
Jan 5, 2022

Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium

Recruiting
  • Hereditary Angioedema
  • +11 more
  • PHA-022121 low dose
  • +3 more
  • Birmingham, Alabama
  • +7 more
Dec 5, 2022

Hereditary Angioedema, HAE Trial in United States (Dose 1 of BMN 331, Dose 2 of BMN 331, Dose 3 of BMN 331)

Recruiting
  • Hereditary Angioedema
  • HAE
  • Dose 1 of BMN 331
  • +4 more
  • Birmingham, Alabama
  • +11 more
Jan 26, 2023

Hereditary Angioedema (HAE) Trial in Worldwide (Lanadelumab)

Available
  • Hereditary Angioedema (HAE)
  • Angioedema
  • Lanadelumab 150 mg
  • Lanadelumab 300 mg
  • Scottsdale, Arizona
  • +19 more
Sep 16, 2022

Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf))

Completed
  • Hereditary Angioedema
  • C1 esterase inhibitor [human] (C1INH-nf)
  • San Diego, California
  • +5 more
Jun 1, 2021

Angioedema Trial in United States (Lanadelumab)

Recruiting
  • Angioedema
  • Birmingham, Alabama
  • +7 more
Mar 30, 2022

Angioedema Trial in Worldwide (Lanadelumab, Placebo)

Completed
  • Angioedema
  • Birmingham, Alabama
  • +44 more
Oct 24, 2022

Graft Rejection Trial in Germany, United States (Placebo, C1 Esterase Inhibitor (Human))

Completed
  • Graft Rejection
  • Placebo
  • C1 Esterase Inhibitor (Human)
  • Los Angeles, California
  • +4 more
Jun 2, 2021

Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf), Placebo (saline))

Completed
  • Hereditary Angioedema
  • C1 esterase inhibitor [human] (C1INH-nf)
  • Placebo (saline)
  • Scottsdale, Arizona
  • +15 more
Jun 1, 2021

Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf))

Completed
  • Hereditary Angioedema
  • C1 esterase inhibitor [human] (C1INH-nf)
  • Scottsdale, Arizona
  • +29 more
May 19, 2021

CVI - Common Variable Immunodeficiency Trial in Centennial (C1-esterase inhibitor [recombinant] (C1-INH-R))

Completed
  • CVI - Common Variable Immunodeficiency
  • C1-esterase inhibitor [recombinant] (C1-INH-R)
  • Centennial, Colorado
    IMMUNOe Research Centers
Feb 11, 2021

Hereditary Angioedema Trial in United States (C1 inhibitor (human) [C1 INH])

Completed
  • Hereditary Angioedema
  • C1 inhibitor (human) [C1 INH]
  • Scottsdale, Arizona
  • +10 more
Jun 17, 2021

Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf))

Completed
  • Hereditary Angioedema
  • C1 esterase inhibitor [human] (C1INH-nf)
  • Hoover, Alabama
  • +47 more
May 19, 2021

Kidney Failure Trial (Placebo saline solution, Heparin, CINRYZE)

Not yet recruiting
  • Kidney Failure
  • Placebo saline solution
  • +2 more
  • (no location specified)
Oct 21, 2020

Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf), Placebo (saline))

Completed
  • Hereditary Angioedema
  • C1 esterase inhibitor [human] (C1INH-nf)
  • Placebo (saline)
  • Hoover, Alabama
  • +36 more
Jun 3, 2021

Latent Tuberculosis Infection Trial in Taipei (isoniazid and rifapentine)

Recruiting
  • Latent Tuberculosis Infection
  • isoniazid and rifapentine
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 22, 2022

Treatment of Hereditary Angioedema (HAE) Attacks

Recruiting
  • Hereditary Angioedema
  • rhC1INH or pdC1INH
  • Sofia, Bulgaria
  • +16 more
Sep 15, 2020

Genetic Variants in Hereditary Angioedema

Not yet recruiting
  • Hereditary Angioedema With C1 Esterase Inhibitor Deficiency
    • Barcelona, Spain
    • +1 more
    Apr 17, 2023

    Hereditary Angioedema Trial in Netherlands, United States (IONIS-PKK-LRx, Placebo)

    Completed
    • Hereditary Angioedema
    • Scottsdale, Arizona
    • +7 more
    Sep 15, 2022

    Antibody Mediated Rejection of Kidney Transplant Trial in New York (C1-INH (Berinert))

    Completed
    • Antibody Mediated Rejection of Kidney Transplant
    • C1-INH (Berinert)
    • New York, New York
      New York University School of Medicine
    Jul 10, 2019

    Teenagers and Non-histaminergic Angioedema With Normal C1

    Not yet recruiting
    • Hereditary Angioedema (HAE)
    • Angioedema
    • No Intervention
    • (no location specified)
    Jan 5, 2023

    HIV Infected Population With Latent Tuberculosis Trial run by the CC (rifapentene (RPT), darunavir/cobicistat (DRV/c), Isoniazid

    Completed
    • HIV Infected Population With Latent Tuberculosis
    • rifapentene (RPT)
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 15, 2022

    Kidney Failure Trial in Madison (rhC1INH, Saline Solution)

    Unknown status
    • Kidney Failure
    • Madison, Wisconsin
      University of Wisconsin
    Dec 10, 2020

    Tuberculosis Trial in Manaus, Rio De Janeiro (Rifapentine 600 mg and INH 300 mg, Rifapentine 900 mg and INH 900 mg)

    Recruiting
    • Tuberculosis
    • Rifapentine 600 mg and INH 300 mg
    • Rifapentine 900 mg and INH 900 mg
    • Manaus, AM, Brazil
    • +1 more
    Apr 14, 2022

    Haemophilia A Trial in Berlin (NNC0365-3769 (Mim8))

    Recruiting
    • Haemophilia A
    • NNC0365-3769 (Mim8)
    • Berlin, Germany
      Novo Nordisk Investigational Site
    Jan 24, 2023